Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 4, 1998, Pages 451-454

  McDonnell, G V ^a   Hawkins, S A ^a,b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Multiple sclerosis; Northern Ireland; Primary progressive multiple sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; DATA BASE; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; RELAPSE; SEX DIFFERENCE; UNEMPLOYMENT; UNITED KINGDOM; VISUAL IMPAIRMENT;

EID: 0031976599     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.4.451     Document Type: Article

References (36)

1. Weinshenker BG. Natural history of multiple sclerosis. Ann Neurol 1994;36:S6-11.
2. Bonduelle M, Albaranes R. Etude statistique de 145 cas de la sclerose en plaques. Semaine des Hopitaux de Paris 1962; 38:3762-73.
3. Verjans E, Theys P, Delmotte P, et al. Clinical parameters and intrathecal IgG synthesis as prognostic factors in multiple sclerosis. J Neurol 1983;229:155-65.
4. Panelius M. Studies on epidemiological, clinical and etiological aspects of multiple sclerosis. Acta Neurol Scand 1969;45(suppl 39):1-82.
5. Minderhoud JM, van der Hoeven JH, Prange AJA. Course and prognosis of chronic progressive multiple sclerosis. Acta Neurol Scand 1988;78:10-5.
6. McDonnell GV, Hawkins SA. An epidemiological study of multiple sclerosis in Northern Ireland. Neurology 1998 (in press).
7. Thompson AJ, Kermode AG, MacManus DG, et al. Pathogenesis of progressive multiple sclerosis. Lancet 1989;333: 1322-3.
8. Thompson AJ, Kermode AG, MacManus DG, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ 1990;300:631-4.
9. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62.
10. Revesz T, Kidd D, Thompson AJ, et al. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994;117:759-65.
11. Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119:701-8.
12. Davie CA, Barker GJ, Webb S, et al. A proton spectroscopy study of disability in multiple sclerosis. J Neurol 1996;243: S33.
13. Kidd D, Barker GJ, Tofts PS, et al. The transverse magnetic decay characteristics of long standing lesions and normal appearing white matter in MS. J Neurol 1997;244:125-30.
14. Dore-Duffy P, Newman W, Balabanov R, et al. Circulating soluble adhesion molecules in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with disease activity. Ann Neurol 1995;37:55-62.
15. Giovannoni G, Thorpe JW, Kidd D, et al. Soluble E-selectin in multiple sclerosis: clinical and MRI correlation. J Neuroimmunol 1994;54:164.
16. Giovannoni G, Thorpe JW, Kidd D, et al. Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease. J Neurol Neurosurg Psychiatry 1996;60:20-6.
17. Olerup O, Hillert J, Fredrikson S, et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989;86:7113-7.
18. Hillert J, Gronning M, Nyland H, et al. An immunogenetic heterogeneity in multiple sclerosis. J Neurol Neurosurg Psychiatry 1992;55:887-90.
19. Weinshenker BG, Santrach P, Schaid D, et al. Association between class II major histocompatibility complex polymorphisms and the course of multiple sclerosis. Neurology 1995;45:A384.
20. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-11.
21. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
22. Kurtzke JF. A proposal for a uniform minimal record of disability in multiple sclerosis. Acta Neurol Scand 1981; 64(suppl 87):110-29.
23. Mellerup E, Fog T, Raun N, et al. The socio-economic scale. Acta Neurol Scand 1981;64(suppl 87):130-8.
24. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227-31.
25. Van Lambalgen RV, Sanders EACM, D'Amaro J. Sex distribution, age of onset and HLA profiles in two types of multiple sclerosis: a role for sex hormones and microbial infections in the development of autoimmunity. J Neurol Sci 1986;76:13-21.
26. Noseworthy J, Paty D, Wonnacott T, et al. Multiple sclerosis after age 50. Neurology 1983;33:1537-44.
27. Larsen JP, Kvaale G, Riise T, et al. Multiple sclerosis - more than one disease? Acta Neurol Scand 1985;72:145-50.
28. Shepherd DI. Clinical features of multiple sclerosis in north-east Scotland. Acta Neurol Scand 1979;60:218-30.
29. Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerised data processing of 349 patients. Brain 1980;103:281-300.
30. Leibowitz U, Alter M, Halpern L. Clinical studies of multiple sclerosis in Israel 3: clinical course and prognosis related to age. Neurology 1964;14:926-32.
31. Cazzullo CL, Ghezzi A, Marforio S, et al. Clinical picture of multiple sclerosis with late onset. Acta Neurol Scand 1978; 58:190-6.
32. Weinshenker BG, Bass B, Rice GPA, et al. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain 1989;112:133-46.
33. Ormerod IEC, McDonald WI. Multiple sclerosis presenting with progressive visual failure. J Neurol Neurosurg Psychiatry 1984;47:943-6.
34. Comi G, Filippi M, Martinelli V, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995;132:222-7.
35. Vleugels L, Pfennings LEMA, Pouwer F, et al. Psychological functioning in primary progressive versus secondary progressive multiple sclerosis. Br J Med Psychol 1998 (in press).
36. Thompson AJ, Polman CH, Miller DH, et al. Primary progressive multiple sclerosis. Brain 1997;120:1085-96.